+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Arrhythmogenic inherited heart muscle diseases in children

Journal of Electrocardiology 34 Suppl: 151-165
Arrhythmogenic inherited heart muscle diseases in children
The left ventricle (LV) plays a central role in the maintenance of health of children and adults due to its role as the major pump of the heart. In cases of LV dysfunction, a significant percentage of affected individuals develop signs and symptoms of congestive heart failure, leading to the need for therapeutic intervention. Therapy for these patients include anticongestive medications and, in some, placement of devices such as aortic balloon pump or left ventricular assist device, or cardiac transplantation. In the majority of patients the origin is unknown, leading to the term idiopathic dilated cardiomyopathy. During the past decade, the basis of LV dysfunction has begun to unravel. In approximately 30% to 40% of cases, the disorder is inherited; autosomal dominant inheritance is most common (although X-linked, autosomal recessive and mitochondrial inheritance occurs). In the remaining patients, the disorder is presumed to be acquired, with inflammatory heart disease playing an important role. In the case of familial dilated cardiomyopathy, the genetic basis is beginning to unfold. To date, 2 genes for X-linked familial dilated cardiomyopathy (dystrophin, G4.5) have been identified and 4 genes for the autosomal dominant form (actin, desmin, lamin A/C, delta-sarcoglycan) have been described. In 1 form of inflammatory heart disease, coxsackievirus myocarditis, inflammatory mediators, and dystrophin cleavage play a role in the development of LV dysfunction. This review describes the molecular genetics of LV dysfunction and provide evidence for a "final common pathway" responsible for the phenotype.

(PDF 0-2 workdays service: $29.90)

Accession: 045301886

PMID: 11781950

Related references

Inherited arrhythmogenic diseases: the complexity beyond monogenic disorders. Circulation Research 94(2): 140-145, 2004

Gene-specific therapy for inherited arrhythmogenic diseases. Pharmacology & Therapeutics 110(1): 1-13, 2005

Knockin animal models of inherited arrhythmogenic diseases: what have we learned from them?. Journal of Cardiovascular Electrophysiology 18(10): 1117-1125, 2007

The role of implantable loop recorder in the management of inherited arrhythmogenic diseases. Circulation 106(19 Supplement): II 700-II 701, November 5, 2002

The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases. Expert Review of Cardiovascular Therapy 12(4): 499-519, 2014

Use of implantable cardioverter-defibrillator in inherited arrhythmogenic diseases: data from Italian ICD Registry for the years 2001-6. Pacing and Clinical Electrophysiology 32(4): 434-445, 2009

The unstoppable attraction for induced pluripotent stem cells: are they the magic bullet for modeling inherited arrhythmogenic diseases?. Journal of the American College of Cardiology 60(11): 1001-1004, 2012

Assessment of exercise capacity and respiratory muscle oxygenation in healthy children and children with congenital heart diseases. Applied Physiology, Nutrition, and Metabolism 33(3): 434-440, 2008

Electrocardiographic features of inherited diseases that predispose to the development of cardiac arrhythmias, long QT syndrome, arrhythmogenic right ventricular cardiomyopathy/dysplasia, and Brugada syndrome. Journal of Electrocardiology 33 Suppl: 1-10, 2001

Cardiac MR imaging in arrhythmogenic heart diseases. Der Radiologe 47(4): 325-332, 2007